Please use this identifier to cite or link to this item:
|Title:||Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme.||Austin Authors:||Grigg, Andrew P ;Prabahran, Ashvind;Donati, Vanessa;Wong, Eric ;Mason, Kate||Affiliation:||Clinical Haematology||Issue Date:||Aug-2023||Publication information:||Internal Medicine Journal 2023-08; 53(8)||Abstract:||Safe outpatient management of acute leukaemia consolidation cycles may enable substantial savings in admission costs. Safety involves the prompt administration of antibiotics in patients with neutropenic fever. Our unit in a metropolitan tertiary referral hospital analysed a cohort of patients spanning a 10-year period, with two key observations: (i) a high proportion of patients living a substantial distance from hospital and (ii) the high incidence and generally prompt onset of fever after severe neutropenia, suggesting this broad applicability of this approach is unfeasible without addressing travel issues and potentially reducing and/or delaying neutropenic fever with prophylactic antibiotics.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/33631||DOI:||10.1111/imj.16193||ORCID:||0000-0001-6915-7442||Journal:||Internal Medicine Journal||Start page:||1492||End page:||1496||PubMed URL:||37599226||ISSN:||1445-5994||Type:||Journal Article||Subjects:||acute myeloid leukaemia
Leukemia, Myeloid, Acute/drug therapy
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 1, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.